We are live on ! Find out more
OSRHW

OSR Health Warrant
OSRHW

20 hedge funds and large institutions have $730K invested in OSR Health Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 24 → 20 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

81% less capital invested

Capital invested by funds: $3.77M → $730K (-$3.04M)

Holders
20
Holders Change
-4
Holders Change %
-16.67%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$8.62K
2
TSS
Two Sigma Securities
New York
+$1.48K
3
Citadel Advisors
Citadel Advisors
Florida
+$601
4
FTUS
Flow Traders U.S.
New York
+$167
5
UBS Group
UBS Group
Switzerland
+$117

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$17.9K
2
Walleye Trading
Walleye Trading
New York
-$11.3K
3
SCM
Shaolin Capital Management
Florida
-$6.77K
4
AA
AQR Arbitrage
Connecticut
-$3.94K
5
HCM
Heights Capital Management
California
-$3.46K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$585K – – –
HCM
2
Highbridge Capital Management
New York
$31K – – –
PC
3
Periscope Capital
Ontario, Canada
$15.5K -$17.9K -375,900 -48%
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$14K – – –
ASM
5
ATW SPAC Management
New York
$11.8K – – –
CS
6
Clear Street
New York
$11.1K +$8.62K +181,059 +162%
JP Morgan Chase
7
JP Morgan Chase
New York
$10.6K – – –
SCM
8
Saba Capital Management
New York
$9.75K – – –
RCM
9
Rivernorth Capital Management
Florida
$9.5K – – –
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$6K – – –
SCM
11
Shaolin Capital Management
Florida
$6K -$6.77K -142,200 -47%
WAM
12
Wolverine Asset Management
Illinois
$4.52K -$123 -2,591 -2%
CC
13
Centiva Capital
New York
$4K – – –
MTCM
14
Mint Tower Capital Management
Netherlands
$3K – – –
AC
15
Aristeia Capital
Connecticut
$2.86K -$79 -1,659 -2%
TSS
16
Two Sigma Securities
New York
$1.18K +$1.48K +31,018 New
HCM
17
Heights Capital Management
California
$1.13K -$3.46K -72,663 -72%
GF
18
Gabelli Funds
New York
$1.03K – – –
FTUS
19
Flow Traders U.S.
New York
$1K +$167 +3,507 +18%
GCIA
20
Gabelli & Co Investment Advisers
New York
$790 – – –
Citadel Advisors
21
Citadel Advisors
Florida
$505 +$601 +12,620 New
UBS Group
22
UBS Group
Switzerland
$94 +$117 +2,468 New
Walleye Trading
23
Walleye Trading
New York
– -$11.3K -236,430 Closed
AA
24
AQR Arbitrage
Connecticut
– -$3.94K -98,528 Closed
SIA
25
SkyView Investment Advisors
New Jersey
– -$1K -30,000 Closed
1
2

OSRHW Hedge Fund Activity: Q1 2025 in Review

20 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q1 2025, worth a combined $730K — down 81% from $3.77M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of OSRHW and 3 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Clear Street, adding an estimated $8.62K. The largest seller was Periscope Capital, cutting an estimated $17.9K.

  • 20 institutional investors held OSR Health Warrant (OSRHW) as of Q1 2025, down from 24 in Q4 2024.
  • Funds reported $730K of OSR Health Warrant stock for Q1 2025, down 81% quarter-over-quarter.
  • 3 funds opened new OSR Health Warrant positions in Q1 2025 and 7 closed out, a net change of -4 holders.
  • The largest OSR Health Warrant buyer in Q1 2025 was Clear Street, an estimated $8.62K added.
  • The largest OSR Health Warrant seller in Q1 2025 was Periscope Capital, an estimated $17.9K sold.

Based on aggregated 13F filings for Q1 2025.